Amylyx Pharmaceuticals (AMLX): Volume dana dhuwit perusahaan

Logo grafis Amylyx Pharmaceuticals (AMLX)

Amylyx Pharmaceuticals management is currently undergoing a rigorous restructuring following the failure of a key product. The volume of physical cash demonstrates capital adaptability to rates, where the current parameter equals 0.77. Finances are based on insurance company payouts for ALS treatment, while the production capacities of contract partners are being systematically modernized for the manufacture of specialized neuropreparations.

AMLX - Dhuwit awis perusahaan Amylyx Pharmaceuticals Inc ing rentang 04.07.2022 - 21.11.2026

Rincian analitis perusahaan Amylyx Pharmaceuticals

- nilai saham lan prakiraan konsensus rega:
Ringkesan analisis perusahaan:amylyx.com
Sampel barang Amylyx Pharmaceuticals Inc

Liquidity is critical for an investor in Amylyx Pharmaceuticals (AMLX), as it supports the development of ALS therapies amidst a dependence on insurance reimbursement systems. This metric measures the absolute volume of available cash, determining the business's "survival runway" until it reaches the break-even point. Analyzing the cash-on-hand metric allows for an assessment of capital management efficiency and helps eliminate the risks of excessive resource accumulation at the expense of expansion.

Pesaing utama

Volume dana dhuwit perusahaan BIIB|Dana dhuwit perusahaan NBIX (Neurocrine Biosciences)|Dana dhuwit perusahaan Regencell Bioscience Ltd RGC|AXSM (Axsome Therapeutics, Inc.) - Total volume dana dhuwit perusahaan|ACADIA Corp - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Xenon Pharmaceuticals|VKTX (Viking Therapeutics Corp) - Dhuwit awis perusahaan|Supernus Pharmaceuticals (SUPN) - Volume dana dhuwit perusahaan|CPRX (Catalyst Pharma) - Volume dana dhuwit perusahaan|DNLI (Denali Therapeutics Inc.) - Gunggung dana dhuwit perusahaan|Volume dana dhuwit perusahaan HRMY|Biohaven Corp - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan trevitherapeutics.com TRVI|PRAX - Dhuwit awis perusahaan|Anavex Life Sciences Corp - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan CeriBell Corp|Prothena Corporation PLC (PRTA) - Dana dhuwit perusahaan|Alector Therapeutics - Sisa dhuwit perusahaan|Dana dhuwit perusahaan Annexon Biosciences|Cadangan dhuwit perusahaan omeros.com OMER|Dana dhuwit perusahaan Neurogene (NGNE)|Aset likuid perusahaan AC Immune S.A.|Volume dana dhuwit perusahaan VYGR (Voyager Therapeutics Inc)|Sisa dhuwit perusahaan NMRA|scilexholding.com - Volume dana dhuwit perusahaan|TVGN (tevogen.com) - Dhuwit awis lan setara dhuwit awis perusahaan|ACOG: Volume dana dhuwit perusahaan|CGTX: Gunggung dana dhuwit perusahaan|Dana dhuwit perusahaan Inhibikase Therapeutics|Dhuwit awis lan setara dhuwit awis perusahaan SAVA (Cassava)|Dana dhuwit perusahaan Assertio Therapeutics (ASRT)|Coya Therapeutics - Dhuwit awis lan setara dhuwit awis perusahaan|VistaGen Therapeutics, Inc. - Dhuwit awis perusahaan|ovidrx.com (OVID) - Cadangan dhuwit perusahaan|ABOS: Dhuwit awis perusahaan|Cadangan dhuwit perusahaan CervoMed Inc|alteritytherapeutics.com (ATHE) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Clene Nanomedicine|Dhuwit awis perusahaan PEPG|Cadangan dhuwit perusahaan Jupiter Neurosciences JUNS|Dana dhuwit perusahaan Relmada (RLMD)|Aset likuid perusahaan Annovis Bio, Inc.|Volume dana dhuwit perusahaan GRCE (Grace Tx)|Firefly Neuroscience, Inc (AIFF) - Cadangan dhuwit perusahaan|KLTO - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan NeuroSense Therapeutics Ltd|RVPH: Volume dana dhuwit perusahaan|MetaVia, Inc. (MTVA) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan NeurAxis|Volume dana dhuwit perusahaan heliusmedical.com|Dhuwit awis perusahaan PASG (Passage Bio Inc.)|Neuphoria Therapeutics - Dhuwit awis lan setara dhuwit awis perusahaan|Minerva Neurosciences Corp - Dhuwit awis perusahaan|Sisa dhuwit perusahaan ATHA|ADXN - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Alzamend Neuro Inc.|Cyclerion Therapeutics (CYCN) - Dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan PTIX|KTTA (pasitheaclinics.com) - Volume dana dhuwit perusahaan|CRGT (cortigent.com) - Gunggung dana dhuwit perusahaan|Volume dana dhuwit perusahaan ATXI|Dana dhuwit perusahaan BCLI (Brainstorm Cell)|Volume dana dhuwit perusahaan CARA (Cara Therapeutics Inc)|Sisa dhuwit perusahaan CHRO|Eliem Therapeutics Inc. - Volume dana dhuwit perusahaan|ITCI - Volume dana dhuwit perusahaan|Longboard Pharma (LBPH) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Marinus Pharmaceuticals|Dana dhuwit perusahaan NKGen|Volume dana dhuwit perusahaan NeuroBo Pharmaceuticals, Inc.|Volume dana dhuwit perusahaan SAGE|Synaptogenix, Inc - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Trevena TRVN|Posisi dhuwit perusahaan Vigil Neuroscience|Anew Medical Inc. - Volume dana dhuwit perusahaan|Aset likuid perusahaan Cerevel Therapeutics, Inc. CERE